ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2877

Premature Senescence of Naive CD4+ T-Cells in Primary Sjogren’s Syndrome

Patrizia Fasching1, Johannes Fessler2, Andrea Raicht3, Angelika Lackner2, Josef Hermann2, Rusmir Husic1, Sabrina Hammerl4, Winfried Graninger2, Wolfgang Schwinger3, Christian Dejaco1 and Martin Stradner1, 1Department of Rheumatology and Immunology, Medical University of Graz, Graz, Austria, 2Rheumatology and Immunology, Medical University of Graz, Graz, Austria, 3Division of Pediatric Hemato-Oncology, Medical University of Graz, Graz, Austria, 4Medical University of Graz, Graz, Austria

Meeting: 2017 ACR/ARHP Annual Meeting

Date of first publication: September 18, 2017

Keywords: Sjogren's syndrome, T cells and Telomeres

  • Tweet
  • Email
  • Print
Session Information

Date: Tuesday, November 7, 2017

Title: Sjögren's Syndrome II: Pathogenesis, Autoantibodies and T-Cells

Session Type: ACR Concurrent Abstract Session

Session Time: 4:30PM-6:00PM

Background/Purpose:

Lymphopenia is a frequent finding in primary Sjögren’s syndrome (pSS) affecting mostly the CD4+ T-cell population. Here we examine possible underlying defects in thymic output and premature senescence of CD4+ T-cells.

Methods:

We included 47 pSS patients and 50 healthy controls (HCs) in a prospective, cross-sectional study. Patients and HCs were separated into two distinct age-groups for analysis of age-dependent differences (≤48 years [SS n=10, HC n=26]; >48 years [pSS n=37, HC n= 24]). Prevalence of T-cell subpopulations was assessed by flow cytometry according to standard surface staining protocols. Naïve CD4+ T-cells were isolated by MACS technology for telomere length and T-cell receptor excision circle (TREC) assessment by real-time PCR. Moreover, telomerase activity was analyzed according to the Telomeric Repeat Amplification Protocols (TRAP).

Results:

We found lower numbers of CD4+ T-cells in pSS patients compared to age matched healthy controls (560/µl vs. 943/µl, p<0.0001). The reduced naïve subset accounted for most of this difference (203/µl vs. 429/µl, P=0.0001). Furthermore, the number of TRECs in naïve CD4+ T-cells was already reduced in young pSS patients (58 copies/ng DNA vs. 2058 copies/ng DNA, p<0.0001) and was furthermore decreased in older patients (14 copies/ng DNA vs. 117 copies/ng DNA, p=0.000) suggesting reduced thymic output or extensive proliferative history. To test for a proliferative history we performed telomere length as well as telomerase activity analysis. Young patients displayed significantly shortened telomeres compared to age-matched controls (6.5kbp vs. 7.0kbp, p=0.011) while telomeres of old patients were not significantly different from age-matched controls. In healthy individuals shorter telomeres resulted in an elevation of telomerase activity, a finding that we could not observe in pSS patients.

Conclusion:

Our data indicate an extensive replicative history of naïve CD4+ T-cells in pSS resulting in premature shortening of telomeres. In contrast to HC, naïve CD4+ T-cells in pSS are unable to induce telomerase activity. This may lead to the reduction of the naïve CD4+ T-cell pool resulting in CD4+ T-cell lymphopenia.


Disclosure: P. Fasching, None; J. Fessler, None; A. Raicht, None; A. Lackner, None; J. Hermann, None; R. Husic, None; S. Hammerl, None; W. Graninger, None; W. Schwinger, None; C. Dejaco, None; M. Stradner, None.

To cite this abstract in AMA style:

Fasching P, Fessler J, Raicht A, Lackner A, Hermann J, Husic R, Hammerl S, Graninger W, Schwinger W, Dejaco C, Stradner M. Premature Senescence of Naive CD4+ T-Cells in Primary Sjogren’s Syndrome [abstract]. Arthritis Rheumatol. 2017; 69 (suppl 10). https://acrabstracts.org/abstract/premature-senescence-of-naive-cd4-t-cells-in-primary-sjogrens-syndrome/. Accessed .
  • Tweet
  • Email
  • Print

« Back to 2017 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/premature-senescence-of-naive-cd4-t-cells-in-primary-sjogrens-syndrome/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology